Article

Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.

Invest Radiol. 2015 Apr 1; 50 (4): 195-204.
Comparative Study

Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.

Eur J Radiol. 2014 Feb 1; 83 (2): 283-8.
Article

Diffusion-weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy.

J Magn Reson Imaging. 2015 Sep 1; 42 (3): 779-87.